[go: up one dir, main page]

SE9904863D0 - New use - Google Patents

New use

Info

Publication number
SE9904863D0
SE9904863D0 SE9904863A SE9904863A SE9904863D0 SE 9904863 D0 SE9904863 D0 SE 9904863D0 SE 9904863 A SE9904863 A SE 9904863A SE 9904863 A SE9904863 A SE 9904863A SE 9904863 D0 SE9904863 D0 SE 9904863D0
Authority
SE
Sweden
Prior art keywords
drug
growth factor
new use
nerve growth
administrated
Prior art date
Application number
SE9904863A
Other languages
English (en)
Inventor
Thomas Lundeberg
Original Assignee
Medscand Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medscand Medical Ab filed Critical Medscand Medical Ab
Priority to SE9904863A priority Critical patent/SE9904863D0/sv
Publication of SE9904863D0 publication Critical patent/SE9904863D0/sv
Priority to AU27198/01A priority patent/AU2719801A/en
Priority to PCT/SE2000/002698 priority patent/WO2001049313A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9904863A 1999-12-30 1999-12-30 New use SE9904863D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9904863A SE9904863D0 (sv) 1999-12-30 1999-12-30 New use
AU27198/01A AU2719801A (en) 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders
PCT/SE2000/002698 WO2001049313A1 (en) 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904863A SE9904863D0 (sv) 1999-12-30 1999-12-30 New use

Publications (1)

Publication Number Publication Date
SE9904863D0 true SE9904863D0 (sv) 1999-12-30

Family

ID=20418378

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904863A SE9904863D0 (sv) 1999-12-30 1999-12-30 New use

Country Status (3)

Country Link
AU (1) AU2719801A (sv)
SE (1) SE9904863D0 (sv)
WO (1) WO2001049313A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2004118424A (ru) * 2001-11-19 2005-05-10 Новартис АГ (CH) Применение аскомицина для лечения блефарита
DK1891966T3 (da) 2002-12-20 2012-04-02 Lundbeck & Co As H Modulation af neurotrophinaktivitet; fremgangsmåde til screening
PL3225251T3 (pl) 2006-12-21 2020-06-29 H. Lundbeck A/S Modulacja aktywności proneurotrofin
CN101951943A (zh) * 2007-12-20 2011-01-19 赛托斯生物技术公司 神经生长因子偶联物及其用途
AU2013207346A1 (en) * 2012-01-05 2014-06-05 Beech Tree Labs, Inc. Method of treating pain by administration of Nerve Growth Factor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242564A (ja) * 1994-03-02 1995-09-19 Sagami Chem Res Center 骨形成促進剤
AU7214998A (en) * 1997-04-11 1998-11-11 Regents Of The University Of California, The Ngf for the prevention of demyelination in the nervous system
CA2792479A1 (en) * 1998-02-27 1999-09-02 The Trustees Of The University Of Pennsylvania Vaccines, immunotherapeutics and methods for using the same

Also Published As

Publication number Publication date
AU2719801A (en) 2001-07-16
WO2001049313A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
EP1605956A4 (en) ADMINISTRATION OF CAPSAICINOIDES
DE60322436D1 (de) Verabreichung von capsaicinoiden
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
ATE429922T1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
EA200701131A1 (ru) Гелеобразная препаративная форма капсаициноида и способы её применения
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
DE69017654D1 (de) Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
DE69621243D1 (de) Verwendung von bradykininantagonisten zur induzierung oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
ATE222101T1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
DK1343472T3 (da) Thixotropisk næsespray
SE9904863D0 (sv) New use
TW200501934A (en) Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
DE69822276T2 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ATE373482T1 (de) Pharmazeutische zusammensetzung zur lokalen behandlung von hauterkrankungen und hautwunden
US9775995B2 (en) Treating skin ulcers
DE69900774D1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE358490T1 (de) Verwendung einer kombination aus einem purin und einem no-donor zur behandlung und prophylaxe sexueller funktionsstörungen